The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms
Abstract
Huntington's disease is a progressive, degenerative disease characterized by abnormal body movements called chorea, and a reduction of various mental abilities. 3-Nitropropionic acid, an inhibitor of complex II of the electron transport chain, causes Huntington's disease-like symptoms in rodents. Recently, it has been reported that oxidative stress, which is one of the pathological hallmarks of various neurodegenerative disorders, also plays an important role in the pathogenesis of Huntington's disease. The present study was designed to investigate effects of resveratrol, an antioxidant with cyclooxygenase I inhibitory activity, in the 3-nitropropionic acid-induced model of Huntington's disease. Intraperitoneal administration of 3-nitropropionic acid (20 mg/kg for 4 days) caused significant loss of body weight, a decline in motor function (locomotor activity, movement pattern and vacuous chewing movements) and poor retention of memory. Repeated treatment with resveratrol (5 and 10 mg/kg, orally), once daily for a period of 8 days beginning 4 days prior to 3-nitropropionic acid administration, significantly improved the 3-nitropropionic acid-induced motor and cognitive impairment. Biochemical analysis revealed that systemic 3-nitropropionic acid administration significantly increased lipid peroxidation, nitrite levels, and depleted reduced glutathione levels, and decreased succinate dehydrogenase activity in the brains of rats. The results of the present study indicate that resveratrol (5 and 10 mg/kg, orally) significantly reversed 3-nitropropionic acid-induced motor and cognitive impairment, and that the beneficial effects of resveratrol might be attributed to its antioxidant activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Resveratrol also protects against 3-NP induced motor and behavioral deficits198.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [198]
Citations
Cites
Ellman, G. L. (1959) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(59)90090-6 · Cited by 26,824
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J. A., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,061
Mechanisms of lipid peroxide formation in animal tissues
Wills, E. D. (1966) · Biochemical Journal · doi:10.1042/bj0990667 · Cited by 1,355
Mitochondrial dysfunction in neurodegenerative diseases
Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 611
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
Frautschy, S. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00300-1 · Cited by 514
3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin
Ludolph, A. C., He, F., Spencer, P. S., Hammerstad, J. P., & Sabri, M. I. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032212 · Cited by 484
Sinha, K., Chaudhary, G., & Gupta, Y. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01691-0 · Cited by 356
Sharma, M., & Gupta, Y. K. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02083-0 · Cited by 326
Han, Y.-S., Zheng, W., Bastianetto, S., Chabot, J., & Quirion, R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705688 · Cited by 300
Stojanović, S., SPRINZ, H., & Brede, O. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2388 · Cited by 275
Research works printed but not linked: 1
- Zini, 1999, Drugs Exp Clin Res, 25, 87
Cited by
Sorted by citations
SIRT1 in Neurodevelopment and Brain Senescence
Herskovits, A. Z., & Guarente, L. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.028 · Cited by 504
Kennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Tomé‐Carneiro, J., Larrosa, M., González‐Sarrías, A., Tomás-Barberán, F. A., García‐Conesa, M., & Espı́n, J. C. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990407 · Cited by 467
Resveratrol: French Paradox Revisited
Catalgol, B., Batirel, S., Taga, Y., & Ozer, N. K. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00141 · Cited by 449
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Vang, O., Ahmad, N., Baile, C. A., Baur, J. A., Brown, K., Csiszár, A., Das, D. K., Delmas, D., Gottfried, C., Lin, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019881 · Cited by 449
Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 426
Kennedy, D. O., Wightman, E. L., Reay, J. L., Lietz, G., Okello, E. J., Wilde, A., & Haskell, C. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28641 · Cited by 415
Resveratrol: Its Biologic Targets and Functional Activity
Pervaiz, S., & Holme, A. L. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2412 · Cited by 415
Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383
“Neuron 81, 471–483 103 Kumar, P. et al. (2006) Effect of resveratrol on 3-nitropropionic acid-induced”
BackgroundResveratrol as a Therapeutic Agent for Neurodegenerative Diseases
Sun, A. Y., Wang, Q., Simonyi, Á., & Sun, G. Y. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8111-y · Cited by 335
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294
Khan, M. M., Ahmad, A., Ishrat, T., Khan, M. B., Hoda, M. N., Khuwaja, G., Raza, S. S., Khan, A., Javed, H., Vaibhav, K., et al. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.031 · Cited by 279
Neuroprotective Strategies for Neurological Disorders by Natural Products: An update
Rehman, M. U., Wali, A. F., Ahmad, A., Shakeel, S., Rasool, S., Ali, R., Rashid, S. M., Madkhali, H. A., Ganaie, M. A., & Khan, R. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180911124605 · Cited by 272
Zhang, F., Liu, J., & Shi, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.03.043 · Cited by 270
Pallos, J., Bodai, L., Lukácsovich, T., Purcell, J. M., Steffan, J. S., Thompson, L. M., & Marsh, J. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn273 · Cited by 272
Resveratrol supplementation: Where are we now and where should we go?
Novelle, M. G., Wahl, D., Diéguez, C., Bernier, M., & de Cabo, R. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.002 · Cited by 254
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease
Sharma, C., Kim, S., Nam, Y., Jung, U. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094850 · Cited by 253
Candelario-Jalil, E., de Oliveira, A. C. P., Gräf, S., Bhatia, H. S., Hüll, M., Muñoz, E., & Fiebich, B. L. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-25 · Cited by 223
PGC-1α, mitochondrial dysfunction, and Huntington's disease
Johri, A., Chandra, A., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.016 · Cited by 227
Sirtuin deacetylases in neurodegenerative diseases of aging
Herskovits, A. Z., & Guarente, L. (2013) · Cell Research · doi:10.1038/cr.2013.70 · Cited by 230
Energy deficit in Huntington disease: why it matters
Mochel, F., & Haller, R. G. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45691 · Cited by 220
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
Rahman, M. H., Akter, R., Bhattacharya, T., Abdel‐Daim, M. M., Alkahtani, S. H., Arafah, M. W., AL–Johani, N. S., Alhoshani, N. M., Alkeraishan, N., Alhenaky, A., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619024 · Cited by 201
SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases
Manjula, R., Anuja, K., & Alcain, F. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.585821 · Cited by 197
Resveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases
Rocha-González, H. I., Ambriz‐Tututi, M., & Granados‐Soto, V. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00045.x · Cited by 190
Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration
Neal, M. P., & Richardson, J. R. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.11.004 · Cited by 195
Pallàs, M., Casadesús, G., Smith, M. A., Coto‐Montes, A. M., Pelegrı́, C., Vilaplana, J., & Camins, A. (2009) · Current Neurovascular Research · doi:10.2174/156720209787466019 · Cited by 184
Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?
Liddell, J. R. (2017) · Antioxidants · doi:10.3390/antiox6030065 · Cited by 172
Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
Ho, D. J., Calingasan, N. Y., Wille, E. J., Dumont, M., & Beal, M. F. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.05.006 · Cited by 148
Resveratrol as a Therapeutic Agent for Alzheimer’s Disease
Ma, T., Tan, M., Yu, J., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/350516 · Cited by 147
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 139
Divino da Rocha, M., Pereira Dias Viegas, F., Cristina Campos, H., Carolina Nicastro, P., Calve Fossaluzza, P., Alberto Manssour Fraga, C., J. Barreiro, E., & Viegas, C. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711794480429 · Cited by 126
Kumar, P., & Kumar, A. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.0028 · Cited by 120
Self-citationKumar, P., Kalonia, H., & Kumar, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01418.x · Cited by 108
Self-citationIRS2 increases mitochondrial dysfunction and oxidative stress in a mouse model of Huntington disease
Sadagurski, M., Cheng, Z., Rozzo, A., Palazzolo, I., Kelley, G. R., Dong, X., Krainc, D., & White, M. F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46305 · Cited by 107
Willis, L., Shukitt‐Hale, B., & Joseph, J. A. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.26736j · Cited by 106
Chao, J., Li, H., Cheng, K., Yu, M.-S., Chang, R. C., & Wang, M. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.02.004 · Cited by 104
Gao, Y., Chu, S., Li, J., Zhang, Z., Yan, J., Wen, Z.-L., Xia, C., Mou, Z., Wang, Z., He, W., et al. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.107 · Cited by 98
Pasinetti, G. M., Wang, J., Marambaud, P., Ferruzzi, M. G., Gregor, P., Knable, L. A., & Ho, L. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.014 · Cited by 99
Kumar, P., & Kumar, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.013 · Cited by 95
Self-citationHong, I., Lee, H., & Kim, H.-P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087061 · Cited by 92
Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex
Schweiger, S., Matthes, F., Posey, K. L., Kickstein, E., Weber, S. S., Hettich, M. M., Pfurtscheller, S., Ehninger, D., Schneider, R., & Krauß, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12974-4 · Cited by 92
Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases
Pierzynowska, K., Gaffke, L., Cyske, Z., Puchalski, M., Rintz, E., Bartkowski, M., Osiadły, M., Pierzynowski, M., Mantej, J., Piotrowska, E., et al. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0214-6 · Cited by 93
Effects of pterostilbene and resveratrol on brain and behavior
Poulose, S. M., Thangthaeng, N., Miller, M. G., & Shukitt‐Hale, B. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.017 · Cited by 89
Resveratrol: botanical origin, pharmacological activity and applications
Wu, C., Yang, J., Wang, F., & Wang, X. (2013) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(13)60001-1 · Cited by 88
Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro
Walter, C., Clemens, L. E., Müller, A. J., Fallier‐Becker, P., Proikas‐Cezanne, T., Rieß, O., Metzger, S., & Nguyen, H. P. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.041 · Cited by 85
Tabeshpour, J., Mehri, S., Behbahani, F. S., & Hosseinzadeh, H. (2018) · Phytotherapy Research · doi:10.1002/ptr.6168 · Cited by 82
Orsu, P., Murthy, B. V. S. N., & Akula, A. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-0982-4 · Cited by 78
Tasset, I., Pontes, A. J., Hinojosa, A. J., de la Torre, R., & Túnez, I. (2011) · Nutritional Neuroscience · doi:10.1179/1476830511y.0000000005 · Cited by 77
Sirtuin Acetylation and Deacetylation: a Complex Paradigm in Neurodegenerative Disease
Khan, H., Tiwari, P., Kaur, A., & Singh, T. G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02387-w · Cited by 75
Binawade, Y., & Jagtap, A. G. (2013) · Journal of Medicinal Food · doi:10.1089/jmf.2012.2698 · Cited by 75
Kumar, P., & Kumar, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.04.058 · Cited by 75
Self-citationThangarajan, S., Deivasigamani, A., Natarajan, S. S., Krishnan, P., & Mohanan, S. K. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2013.872642 · Cited by 71
Kumar, P., Kalonia, H., & Kumar, A. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.11.030 · Cited by 69
Self-citationLum, P. T., Sekar, M., Gan, S. H., Bonam, S. R., & Shaikh, M. F. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00824 · Cited by 68
Neuroprotective effects of resveratrol in Alzheimer rsquo s disease
Murlimanju, B. V. (2019) · Frontiers in Bioscience-Elite · doi:10.2741/e863 · Cited by 67
Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity
Kumar, P., Kalonia, H., & Kumar, A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.10.001 · Cited by 66
Self-citationMehan, S., Parveen, S., & Kalra, S. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.200812 · Cited by 65
Kumar, P., & Kumar, A. (2009) · Neuroscience Research · doi:10.1016/j.neures.2009.01.005 · Cited by 63
Self-citationStilbenes and Anthocyanins Reduce Stress Signaling in BV-2 Mouse Microglia
Carey, A. N., Fisher, D. R., Rimando, A. M., Gomes, S. M., Bielinski, D. F., & Shukitt‐Hale, B. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf400342g · Cited by 60
Bhateja, D., Dhull, D. K., Gill, A., Sidhu, A., Sharma, S., Reddy, B. V. K., & Padi, S. S. V. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.029 · Cited by 60
Self-citationEffects of 90 Days of Resveratrol Supplementation on Cognitive Function in Elders: A Pilot Study
Anton, S. D., Ebner, N. C., Dzierzewski, J. M., Zlatar, Z. Z., Gurka, M. J., Dotson, V. M., Kirton, J. W., Mankowski, R. T., Marsiske, M., & Manini, T. M. (2018) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0398 · Cited by 60
Kumar, A., Chaudhary, T., & Mishra, J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.057 · Cited by 59
Self-citationKumar, A., & Goyal, R. (2008) · Journal of Medicinal Food · doi:10.1089/jmf.2006.0207 · Cited by 58
Self-citationKumari, B., Kumar, A., & Dhir, A. (2007) · PubMed · Cited by 58
Self-citationTargeting Sirtuin-1 in Huntington’s Disease: Rationale and Current Status
Duan, W. (2013) · CNS Drugs · doi:10.1007/s40263-013-0055-0 · Cited by 54
Kumar, P., Kalonia, H., & Kumar, A. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2010.00537.x · Cited by 54
Self-citationHistone deacetylases as targets for the treatment of human neurodegenerative diseases
D’Mello, S. R. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.9.1437959 · Cited by 53
Estrogens of multiple classes and their role in mental health disease mechanisms
Watson, C. S. (2010) · International Journal of Women s Health · doi:10.2147/ijwh.s6907 · Cited by 55
Sirtuins Expression and Their Role in Retinal Diseases
Balaiya, S., Abu‐Amero, K. K., Kondkar, A. A., & Chalam, K. V. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3187594 · Cited by 52
Kumar, P., Kalonia, H., & Kumar, A. (2009) · Journal of Asian Natural Products Research · doi:10.1080/10286020902862194 · Cited by 52
Self-citationTerracina, S. A., Petrella, C., Francati, S., Lucarelli, M., Barbato, C., Minni, A., Ralli, M., Greco, A., Tarani, L., Fiore, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415674 · Cited by 56
Dhull, D. K., Jindal, A., Dhull, R. K., Aggarwal, S., Bhateja, D., & Padi, S. S. V. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9583-6 · Cited by 50
Self-citationKumar, P., Kalonia, H., & Kumar, A. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833a5bf4 · Cited by 47
Self-citationEffect of resveratrol on scopolamine-induced cognitive impairment in mice
Rachna, G., Lalit, K., Pramod, K. M., & Swapan, K. B. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70785-5 · Cited by 46
Gendy, A. M., El-Sadek, H. M., Amin, M. M., Ahmed, K. A., El-Sayed, M. K., El-Haddad, A. E., & Soubh, A. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121317 · Cited by 45
Kumar, P., & Kumar, A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1652-y · Cited by 43
Self-citationSumathi, T., Asha, D., Nagarajan, G., Sreenivas, A., & Nivedha, R. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.01.008 · Cited by 40
Resveratrol: A Natural Compound Targeting the PI3K/Akt/mTOR Pathway in Neurological Diseases
Utpal, B. K., Mokhfi, F. Z., Zehravi, M., Sweilam, S. H., Gupta, J. K., Kareemulla, S., Ronald Darwin, C., Rao, A. A., Kumar, V. V., Krosuri, P., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04608-4 · Cited by 37
Berberine Ameliorate Haloperidol and 3-Nitropropionic Acid-Induced Neurotoxicity in Rats
Kadir, A., Singh, J., Rahi, V., & Kumar, P. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03677-y · Cited by 36
Self-citationUpadhayay, S., Yedke, N. G., Rahi, V., Singh, S., Kumar, S., Arora, A., Chandolia, P., Kaur, P., Kumar, M., Koshal, P., et al. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03868-1 · Cited by 36
Self-citationMalik, J., Choudhary, S., & Kumar, P. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2014.984856 · Cited by 35
Self-citationKumar, A., Sharma, S., Prashar, A., & Deshmukh, R. R. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0414-4 · Cited by 33
Self-citationHaley, R. M., Zuckerman, S. T., Dakhlallah, H., Capadona, J. R., von Recum, H. A., & Ereifej, E. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103579 · Cited by 32
Dhir, A., Akula, K. K., & Kulkarni, S. K. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.12.017 · Cited by 31
Ali‐Seyed, M., Ayesha, S., Azmi, N., Al-Rabae, F. M., Alalawy, A. I., Alzahrani, O. R., & Hawsawi, Y. M. (2021) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-021-00295-3 · Cited by 32
Kumar, P., Kalonia, H., & Kumar, A. (2010) · Drug and Chemical Toxicology · doi:10.3109/01480541003642050 · Cited by 30
Self-citationRole of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats
Kumar, P., Kumar, P., Khan, A. G., Deshmukh, R. R., & Sharma, P. L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.11.036 · Cited by 29
Self-citationSocała, K., Żmudzka, E., Lustyk, K., Zagaja, M. P., Brighenti, V., Costa, A., Andres‐Mach, M., Pytka, K., Martinelli, I., Mandrioli, J., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8101 · Cited by 29
Szalárdy, L., Zádori, D., Klivènyi, P., Toldi, J., & Vécsei, L. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/498401 · Cited by 30
Hanna, D. M. F., Tadros, M. G., & Khalifa, A. E. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.005 · Cited by 28
Linard, C. F. B. M., Andrade‐da‐Costa, B. L. D. S., Augusto, R. L., Sereniki, A., Trevisan, M. T. S., Perreira, R. D. C. R., de Souza, F. T. C., Braz, G. R. F., Lagranha, C. J., de Souza, I. A., et al. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9882-6 · Cited by 28
Effects of Mediterranean Diet Components on Neurodegenerative Diseases
Farooqui, A. A., & Farooqui, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811959-4.00001-8 · Cited by 28
Mitochondrial Effects of Plant-Made Compounds
Biasutto, L., Szabó, I., & Zoratti, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4021 · Cited by 25
Upadhayay, S., Jamwal, S., & Kumar, P. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2201493 · Cited by 24
Self-citationÖZAÇMAK, V. H., ÖZAÇMAK, H. S., & Barut, F. (2015) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000027 · Cited by 24
Organoselenium Bis Selenide Attenuates 3-Nitropropionic Acid-Induced Neurotoxicity in Rats
Bortolatto, C. F., Jessé, C. R., Wilhelm, E. A., Chagas, P. M., & Nogueira, C. W. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9336-5 · Cited by 24
Wang, H. C., & Brumaghim, J. L. (2011) · ACS symposium series · doi:10.1021/bk-2011-1083.ch005 · Cited by 23
A Novel Pharmacological Protective Role for Safranal in an Animal Model of Huntington’s Disease
Fotoohi, A., Moloudi, M. R., Hosseini, S., Hassanzadeh, K., Feligioni, M., & Izadpanah, E. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03271-8 · Cited by 24
Kumar, R., Kumar, R., Khurana, N., Singh, S. K., Khurana, S., Verma, S., Sharma, N., Vyas, M., Dua, K., Khursheed, R., et al. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-19428-z · Cited by 24
Kalonia, H., Kumar, P., Nehru, B., & Kumar, A. (2009) · PubMed · Cited by 23
Self-citation
Metadata
- Authors
- Kumar, P., Padi, S. S., Naidu, P. S., & Kumar, A.
- Affiliations
- Panjab University (IN)
- Corresponding author
- Kumar, Puneet
- Kumar, Anil
- Venue
- Behavioural Pharmacology
- Published
- 2006-09
- Volume
- 17
- Issue
- 5-6
- Pages
- 485-492
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W1974431794
- Cited by
- 167
- References
- 36
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 8 · 2023: 3 · 2022: 6 · 2021: 10 · 2020: 7 · 2019: 2 · 2018: 7 · 2017: 9 · 2016: 5 · 2015: 10 · 2014: 4 · 2013: 16 · 2012: 12
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Behavioural Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- resveratrol, 3-nitropropionic acid, Huntington's disease, neuroprotection, oxidative stress, antioxidant activity, motor impairment, cognitive impairment, lipid peroxidation, glutathione depletion, nitrite, succinate dehydrogenase, complex II inhibition
- MeSH terms
- Resveratrol, Animals, Antioxidants, Behavior, Animal, Brain, Cell Survival, Glutathione, Huntington Disease, Injections, Intraperitoneal, Male, Motor Activity, Neurons, Neurotoxins, Nitro Compounds, Propionates, Retention, Psychology, Stereotyped Behavior, Stilbenes, Succinate Dehydrogenase, Lipid Peroxidation, Rats, Wistar, Neuroprotective Agents, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
